托克索普拉斯马淋巴菌效应剂MAF1通过抑制mtDNA释放来阻止小鼠AIM2炎症酶的激活
Xiao-Yu Zhao1, Nadia K Holness1, Samantha L Lempke1
1Department of Microbiology, Immunology, and Cancer Biology at the Carter Immunology Center, University of Virginia School of Medicine, Charlottesville, VA, United States.
Journal of immunology (Baltimore, Md. : 1950)
|March 1, 2026
概括
干扰因子- (IFN-γ) 启动Toxoplasma gondii感染,以使用宿主线粒体DNA (mtDNA) 激活AIM2炎症体. 一种寄生因子MAF1I通过在真空中保留mtDNA来抑制这一过程.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 细胞生物学 细胞生物学
背景情况:
- 毒素菌是一种细胞内病原体,影响宿主免疫力.
- 炎症酶激活,托尔类受体 (TLRs) 和干扰素- (IFN-γ) 信号调节T. gondii感染.
- 在T. gondii感染期间,IFN-γ信号和炎症酶激活之间的相互作用需要进一步阐明.
研究的目的:
- 调查T. gondii感染期间IFN-γ信号和炎症酶激活之间的合作的分子机制.
- 为了识别参与宿主对T. gondii的反应的炎症体传感器和连接体.
- 探索寄生虫因子在调节宿主炎症酶激活中的作用.
主要方法:
- 使用了被T. gondii感染的小鼠髓状细胞.
- 通过IL-1β释放,酶-1/11,ASC和NLRP3.3进行评估的炎症酶激活.
- 研究了黑色素瘤2 (AIM2) 炎症体和线粒体DNA (mtDNA) 中缺席的作用.
- 研究了来自I型T. gondii的线粒体关联因子1 (MAF1I) 的功能.
主要成果:
- IFN-γ足以主导T. gondii诱导的炎症酶激活.
- AIM2炎症酶,以及-1/11,ASC和NLRP3,主导IL-1β的释放.
- AIM2炎症酶激活独立于杀死寄生虫,但依赖于宿主mtDNA作为连接体.
- 寄生虫因子MAF1I抑制mtDNA释放和随后的炎症酶激活.
结论:
- 在IFN-γ信号下,T. gondii感染会通过宿主mtDNA触发AIM2炎症酶激活.
- MAF1I通过隔离mtDNA来竞争性地抑制这种宿主反应.
- 这项研究揭示了一种新的宿主-病原体相互作用机制,涉及宿主DNA传感和寄生虫免疫逃避.
更多相关视频
09:52Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii
Published on: July 12, 2013
17.7K
11:21Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
Published on: March 12, 2015
11.5K
相关概念视频
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...